The discovery of leptin has had a transforming effect on the science of body weight and obesity during the last 7 y. 1 Leptin, a hormone secreted by fat in proportion to its quantity, provides information necessary for body fat homeostasis. In the lipostatic theory of body weight regulation, the brain can use leptin signaling to tune its responses, appetite and energy expenditure, so as to maintain a constant fat mass. Disorders of body weight such as anorexia and obesity would therefore be dysregulations of this lipostatic system, not manifestations of disordered character. Early hopes that exploitation of leptin in this context would 'cure' many obesities are as yet unrealized. Further, it is clear that nearly all the obese have high, sometimes very high, leptin levels yet do not respond with appropriate reduction in appetite or increase in expenditure. Recognition of these complexities has led to efforts to better understand how leptin works in the brain.
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It is likely that the most significant leptin related development has been insight concerning brain mechanisms governing appetite and body weight. Crucial leptin receptors are found in the brain, notably in the arcuate nucleus of the hypothalamus, but also in other brain areas. Following the leads provided by these leptin receptors, as well as by an encouraging array of related genetic developments, has propelled important new observations.
The sophistication of knowledge about leptin and leptin response in the brain has begun. Evidence described in this section indicates that leptin responsive brain mechanisms respond in more than one way and at more than one site. Leptin brain actions are differentiated with respect to such variables as time course, type of energy balance alteration, and so on. Leptin-responsive neurons also respond to other energy-related signals, suggesting that integration of signaling, both leptin and non-leptin related, may be occurring. These complications, and others to come, make possible a contextual understanding of leptin action in the brain, and lead toward an explanation for why elevated leptin levels in the obese do not induce a body weight correction and why some 'resist' the effects of administered leptin.
In the first perspective, Gregory Morton and Michael Schwartz describe evidence concerning NPY=AgRP neurons in the arcuate nucleus of the hypothalamus. 2 These neurons exert an influence referred to by Dr Schwartz as anabolic signals. Both of the released neurochemical products, neuropeptide Y (NPY) and agouti-related peptide (AgRP) increase food intake and body weight through interaction at receptors in the paraventricular nucleus, a principal site of arcuate nucleus projection. NPY directly increases food intake, while tonically inhibitory melanocortin signaling is antagonized by AgRP, thus allowing increased food intake complementary to the NPY effect. Neurons that make these neurochemicals express the leptin receptor, providing a clear linkage between leptin peripheral signaling and neurochemical activity in the projection between the arcuate and paraventricular nuclei. There is strong evidence that these neurons respond appropriately to changes in leptin levels and to a variety of changes in energy balance including fasting, uncontrolled diabetes, and genetic deficiencies of leptin.
New information about how these neurochemicals work provides differentiating properties to the system. Neuropeptide Y has a significantly shorter duration of action within the arcuate to PVN projection than AgRP. Therefore, although the signaling properties of NPY and AgRP can in some ways be viewed as redundant, the difference in duration of action indicates potential differences in effect. These differences are further heightened by the observation that AgRP mRNA responds much more dramatically to fasting and genetic leptin deficiency than do NPY mRNA levels within the same brain site. Indications that more than redundancy is involved are also provided by evidence regarding neuropeptide Y knockout mice made diabetic with streptozotocin. Streptozotocin diabetes has effects of similar magnitude on both NPY and AgRP in NPY-competent animals. NPY knockout mice have normal responses to fasting and exhibit normal daily food intake, but NPY knockout mice do not increase food intake normally in streptozotocininduced diabetes. These data suggest that AgRP provides some, but not all, of the influences provided by NPY. Overall these data suggest a system characterized in part by redundancy but also in part by differentiation of response based on physiologic context. Joel Elmquist expands the consideration of leptin effects on arcuate nucleus neurons. 3 Evidence provided by Dr Elmquist indicates that leptin activates neurons that express pro-opiomelanocortin (POMC) and cocaine-and amphetamine-related transcript (CART) messenger RNA. Leptin increases expression of a marker of neural activation, fos, as well as an indicator of suppressed cytokine signaling (SOCS3) messenger RNA in POMC neurons. Leptin also increases expression of SOCS3 in NPY=AgRP neurons but it does not increase fos, suggesting that the leptin effect on arcuate nucleus cells is differentiated based on their chemical phenotype: NPY=AgRP vs POMC. Mechanisms therefore appear to be in place, which allow leptin to suppress anabolic and stimulate catabolic pathways in the arcuate to paraventricular connection. Dr Elmquist has further found that the pro-opiomelanocortin neurons in the arcuate nucleus project both to the paraventricular nucleus and to the lateral hypothalamus. The lateral hypothalamus is of considerable current interest because of recognition that other influences on food intake and body weight can be found there, notably melanin-concentrating hormone (MCH) and orexin-containing neurons. The projection from arcuate to lateral hypothalamus provides additional response pathways which may subsequently project into several hypothalamic nuclei, including back to arcuate and paraventricular nuclei, as well as to other brain regions. The possibility of additional signaling, both related and unrelated to leptin, is raised by these diverse projections but limited data currently address this issue.
Roger Cone emphasizes the importance of leptin action on arcuate nucleus POMC as well as NPY=AgRP neurons. 4 Arcuate POMC neuron responsiveness in a hypothalamic slice preparation has been determined using patch clamp recordings. POMC neurons are activated by leptin, consistent with the fos activation data described by Dr Elmquist. However there appear to be two mechanisms underlying the leptin-induced activation. The functional significance of these different mechanisms is still to be determined. The population of arcuate POMC-expressing neurons appears to be sub-divided further by responsiveness to a key neuropeptide derivative of POMC, melanocyte stimulating hormone (MSH) acting on melanocortin receptors. Between 30 and 50% of POMC neurons are inhibited by a gamma MSH agonist, suggesting that the melanocortin 3 receptor may play an auto-inhibitory role on that subpopulation of POMC neurons. In addition the patch clamp recordings confirm that these arcuate neurons respond to a number of metabolic stimuli, perhaps indicating that more than leptin is involved in determining their signaling characteristics. Dr Cone's discussion further expands the scope by including ghrelin, an endogenous ligand of the growth hormone secretagog receptor. Ghrelin is secreted by the stomach after meals and has a short half-life, but appears to act on receptors in the arcuate nucleus. Implicating arcuate neurons in responses to metabolic perturbations and additional peripheral signals such as ghrelin, and differentiating arcuate POMC neurons based on functional characteristics both suggest a rich network of brain mechanisms complementary to leptin based lipostasis.
Barry Levin explores an additional property of neurons in the arcuate nucleus projecting to the paraventricular nucleus and other sites. 5 Some neurons increase and others decrease their firing rate as a function of brain glucose levels. Those neurons that increase their firing rate in response to glucose, glucose responsive neurons, are characterized by two cellular components, an ATP-sensitive potassium channel and the presence of glucokinase. Glucokinase modulates potassium channel activity as a function of glycolytic production of ATP. Current evidence suggests that glucokinase may be a marker for glucose responsive neurons characterized by increased firing rate with glucose. Both NPY and POMC neurons in the arcuate nucleus contain potassium channel and glucokinase components in addition to the leptin receptors described above. These neurons are known to receive a variety of inputs from other brain sites. Dr Levin suggests that metabolism-related signals could be summated through the potassium channel activity and this activity could then be linked to the rate of peptide or neurotransmitter release. In this way these neurons could act not only as responders to leptin levels but also as sites where more than one type of energy related signal could be integrated.
Harvey Grill and Joel Kaplan provide a very different outlook on the control mechanisms thus far considered. 6 Evidence indicates that the effective form of the leptin receptor can be found in the brainstem as well as in the hypothalamus. These receptors appear to be functional because delivery of leptin into brainstem sites suppresses food intake. In addition, melanocortin and corticotropinreleasing hormone receptors and functional responsiveness have been found in the brainstem. These new observations have been made on a background of evidence indicating that the brainstem provides some of the responses needed to govern food intake. A decerebrate rat preparation continues to integrate taste and peripheral signals in a way that allows regulation of meal size. Dr Grill argues that these observations are consistent with a model for the brain mechanisms regulating appetite and energy balance that is distributionist in nature. In this model the brainstem and hypothalamus would participate, potentially along with other brain sites, in a network response to leptin, changes in body energy stores, and changes in energy balance generally. In the distributionist model it would be crucial to include brain responses outside the hypothalamus to understand the brain mechanisms involved.
Synthesizing these observations, it is clear that there is a very strong forebrain response to leptin located principally in the arcuate nucleus and projecting most importantly to the paraventricular nucleus within the hypothalamus. Evidence indicates that responsiveness within this projection can play a strong regulating role on food intake as well as energy expenditure and overall energy balance. Leptin responsiveness of this portion of the system is dramatic, affecting both positive and negative energy balance signals in a complementary fashion. This evidence links peripheral leptin signaling and energy balance regulation within the brain. As studies continue, the system appears to be more differentiated and more complex. Neurons within the arcuate nucleus project not only to the paraventricular nucleus but also to other hypothalamic and extra hypothalamic sites, which also provide reciprocal projections back to the arcuate and the hypothalamus. The crucial observation that brainstem sites also express functional leptin receptors indicates that sites outside of the hypothalamus also participate in leptin responsiveness. Each of the papers provides evidence for differential responsiveness of critically involved neurons, with differences based on brain site, neuronal type (including subpopulations within similar neurons), and mode of energy balance alteration. Metabolic changes, notably glucose levels, can be sensed and presumably integrated both within the arcuate nucleus and most likely at other brain sites as well. The implication that many brain sites, at minimum several hypothalamic and brainstem nuclei, must communicate in the process of achieving appetite and body weight regulation is inescapable.
